newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the